Webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence [BE/BA News]

posted by Achievwin – US, 2023-02-07 08:13 (808 d 22:00 ago) – Posting: # 23441
Views: 7,521

Wishful thinking: I hope they give clear direction (kill once for all) - the annoying center/group effect portion for BE studies conducted in one country and in homogenous population.

As many times and on many platforms they mentioned it is irrelevant in BE/ANDA contecxt some academic curiosity folks keep brining this topic and keep the topic alive.

❝ FDA is organizing a webinar: A Deep Dive: FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence


Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
25 visitors (0 registered, 25 guests [including 9 identified bots]).
Forum time: 07:13 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5